Koele, S.E.* et al. Population pharmacokinetics and exposure-response relationship of the antituberculosis drug BTZ-043. J. Antimicrob. Chemother. 80, 1315-1323 (2025)
Koele, S.E.* et al. Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TB. J. Antimicrob. Chemother. 80, 2305-2313 (2025)
Walter, K.* et al. Investigating the treatment shortening potential of a combination of bedaquiline, delamanid and moxifloxacin with and without sutezolid, in a murine tuberculosis model with confirmed drug exposures. J. Antimicrob. Chemother. 79, 2607-2610 (2024)